ClearBridge Investments’s Caris Life Sciences CAI Stock Holding History

ClearBridge Investments’s Portfolio CAI Stock Details CAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.4M	Buy	1,595,877 +44,103	+3%	+$789K	0.02%	400
2026 Q1	$27.7M	Buy	1,551,774 +135,567	+10%	+$2.96M	0.02%	396
2025 Q4	$38.2M	Buy	1,416,207 +34,977	+3%	+$985K	0.03%	360
2025 Q3	$41.8M	Buy	1,381,230 +124,105	+10%	+$3.96M	0.03%	355
2025 Q2	$33.6M	Buy	+1,257,125	New	+$33.9M	0.03%	367

Other funds holding CAI

JHWEPV

J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Los Angeles Capital Management Los Angeles, California $27.2B AUM 43.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

ClearBridge Investments's CAI Position: Q2 2026 in Review

ClearBridge Investments increased its Caris Life Sciences (CAI) stake by 2.8% in Q2 2026, buying an estimated $789K and bringing the position to 1,595,877 shares worth $28.4M. The position accounts for 0.02% of the portfolio, ranked #400.

ClearBridge Investments first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. The position peaked at $41.8M in Q3 2025. 164 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

ClearBridge Investments held 1,595,877 shares of Caris Life Sciences worth $28.4M as of Q2 2026.
ClearBridge Investments bought 44,103 Caris Life Sciences shares in Q2 2026, an estimated $789K.
Caris Life Sciences made up 0.02% of ClearBridge Investments's portfolio in Q2 2026, its #400 holding.
ClearBridge Investments first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
ClearBridge Investments's Caris Life Sciences position peaked at $41.8M in Q3 2025.
164 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.